The low osteocalcin levels of glucocorticoid treated patients can be brought to normal by nandrolone decanoate administration.

TL;DR: It is shown that muscle-building exercise is associated with increase in BMC and BD also at non-weight bearing sites, and that anabolic steroids did not provide, at the time of the observation, any further stimulus for osteoblast activity and bone formation.

TL;DR: Although optimal prophylaxis and therapy for glucocorticoid-induced osteoporosis have not been established, a number of recommendations can be made for glucose-dependent asthmatics and patients with substantial bone loss.

TL;DR: Nandrolone decanoate therapy may be used in the prevention of CST-induced osteoporosis because it also seems to exert mild inhibition of bone resorption without affecting or even stimulating bone formation.